71.38MMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-07-31The current institutional shareholding score of Gain Therapeutics Inc is 3.00, ranking 192 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 20.25%, representing a quarter-over-quarter increase of 58.16%. The largest institutional shareholder is Bill Nygren | OAKMX, holding a total of 621.47K shares, representing 1.34% of shares outstanding, with 10.07% decrease in holdings.
Institutional Shareholding
Shareholder Activity
Potomac Capital Management Inc.
Susquehanna International Group, LLP
Cambridge Investment Research Advisors, Inc.
Geode Capital Management, L.L.C.